Recombinant Bovine Somatotropin vs Aspartame: which is worse?

What is Recombinant Bovine Somatotropin?

Recombinant bovine somatotropin (rBST) is the synthetic version of bovine growth hormone (BST), naturally produced by the pituitary gland in cattle. The recombinant version is produced using genetically engineered bacteria and is injected into dairy cows to increase milk production by 10-15%. Brand name: Posilac.

What is Aspartame?

Aspartame is a low-calorie synthetic dipeptide sweetener composed of two amino acids — phenylalanine and aspartic acid — bonded with methanol. When metabolized, it breaks down into these three components. It is approximately 200 times sweeter than sucrose, so tiny amounts provide significant sweetness with almost no calories.

Documented risks

Recombinant Bovine Somatotropin: See recombinant-bovine-growth-hormone-rbgh for full detail. Key concerns: rBST elevates IGF-1 in milk; elevated blood IGF-1 is associated with breast, prostate, and colorectal cancer risk in epidemiological studies. Animal welfare: increased mastitis (up to 25-50% higher rates), lameness, and antibiotic use. The Codex Alimentarius Commission declined to endorse rBST safety MRLs in a historic 33-29 vote. Health Canada rejected rBST approval in 1999 after finding it caused significant animal health problems requiring increased antibiotic use.

Aspartame: Aspartame has been one of the most studied food additives in history, with over 200 regulatory studies reviewed by multiple agencies. The FDA and EFSA have repeatedly reaffirmed its safety at permitted levels for the general population. IARC classification controversy (2023): In July 2023, IARC classified aspartame as Group 2B (possibly carcinogenic to humans), based primarily on limited evidence from human epidemiological studies associating aspartame intake with hepatocellular carcinoma (liver cancer) in some observational studies. Notably, the WHO Joint Expert Committee on Food Additives (JECFA) simultaneously re-evaluated aspartame and maintained the ADI at 40 mg/kg/day, concluding that the evidence does not establish that aspartame causes cancer at typical intake levels. This rare split between IARC (hazard identification) and JECFA (risk assessment) created significant public confusion. Phenylketonuria (PKU): Aspartame is definitively harmful for individuals with phenylketonuria — a genetic disorder affecting phenylalanine metabolism. People with PKU cannot process phenylalanine normally, and aspartame consumption can cause severe neurological damage. This is why all aspartame-containing products must carry a PKU warning on US and EU labels. Methanol release: aspartame metabolism releases methanol (~10% by weight). Critics including independent researcher Woodrow Monte have argued that methanol from aspartame is harmful, citing methanol's conversion to formaldehyde and formic acid in the body. However, methanol released from aspartame is a fraction of the methanol obtained from fresh fruit juices, and regulatory agencies consider the amounts released too small to be clinically significant. Gut microbiome concerns: a 2021 Cell study found that aspartame and other sweeteners altered gut microbiome composition and glucose tolerance in humans. These microbiome effects are an emerging area of research.